- Supported exchanges /
- F /
- 3VG.F
THERANEXUS EO -25 (3VG F) stock market data APIs
€0.468
0(0%)
as of October 29, 2024
Price chart is built with Anychart
Theranexus Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was founded in 2013 and is headquartered in Lyon, France.
THERANEXUS EO -25 Financial Data Overview
0.468 | |
0.468 | |
- | |
0.468 | |
0.468 | |
0.434-1.22 | |
4 175 K | |
7 814 K | |
2 265 K | |
2.383 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'3VG',
Type:
'Common Stock',
Name:
'THERANEXUS EO -25',
Exchange:
'F',
CurrencyCode:
'EUR',
CurrencyName:
'Euro',
CurrencySymbol:
'€',
CountryName:
'Germany',
CountryISO:
'DE',
OpenFigi:
NULL,
ISIN:
'FR0013286259',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
THERANEXUS EO -25 Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 265 K
- EBITDA -3 812 487
- Earnings Per Share -0.17
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get THERANEXUS EO -25 Earnings via APIs
- Latest Release 2024-10-23
- EPS/Forecast NaN
Get THERANEXUS EO -25 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: